ロード中...
(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
PURPOSE: In bone-metastatic breast cancer patients, there are no current imaging biomarkers to identify which patients have worst prognosis. The purpose of our study was to investigate if skeletal tumor burden determined by (18)F-Fluoride PET/CT correlates with clinical outcomes and may help define...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482633/ https://ncbi.nlm.nih.gov/pubmed/28415595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16418 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|